Body dysmorphic disorder (BDD) is a psychiatric condition in which a person becomes preoccupied — to a clinically significant and often consuming degree — with one or more perceived flaws in their physical appearance. These flaws are either not noticeable to others at all, or are clearly minor by any objective standard. The distress and impairment caused by this preoccupation, however, can be severe and life-limiting.
BDD is classified in DSM-5 within the obsessive-compulsive and related disorders spectrum — reflecting its phenomenological overlap with OCD, particularly in the intrusive nature of the preoccupying thoughts and the repetitive, compulsive behaviours that follow.
The central feature of BDD is a distorted perception of a specific aspect of appearance around which the person's thoughts become intensely and persistently focused. Any part of the body may be the focus — most commonly skin, nose, hair, eyes, stomach, teeth, or body shape. The person perceives a significant flaw where others see none, or sees a minor variation as grossly disfiguring.
This preoccupation is not vanity or self-consciousness. It is intrusive, distressing, and difficult to control. The person typically spends hours each day thinking about the perceived flaw, checking it in mirrors, seeking reassurance, or going to extraordinary lengths to avoid mirrors entirely. Concealment behaviours are common: specific clothing, heavy makeup, or arranging social situations to avoid exposure.
Muscle dysmorphia is a subtype in which the preoccupation focuses on the belief that one's body is insufficiently muscular. More common in men, it is frequently associated with excessive exercise, disordered eating focused on body composition, and use of appearance-enhancing substances.
BDD must be distinguished from eating disorders — where preoccupation is specifically with weight; normal self-consciousness; and delusional disorder — where insight is absent. In BDD, insight varies: some patients recognise their concerns may be exaggerated; others have little or no insight.
One of the most clinically significant aspects of BDD is the frequency with which affected individuals seek cosmetic or surgical interventions to correct the perceived defect. These interventions consistently fail to resolve the underlying disorder. Patients frequently report that the procedure did not achieve the desired outcome, or that attention has shifted to a new perceived flaw.
BDD is a contraindication to cosmetic procedures. Its identification prior to any aesthetic or surgical intervention is clinically important. Dermatologists, plastic surgeons, and aesthetic practitioners are increasingly aware of BDD as a presentation they may encounter before psychiatric services are involved.
The symptom picture includes persistent intrusive preoccupation with appearance; repetitive behaviours — mirror checking, skin picking, comparing appearance to others; reassurance seeking or avoidance of social situations; significant time consumed by appearance-related thoughts — often several hours per day; avoidance of work, social settings, or intimate relationships; and in severe presentations, social isolation and suicidal ideation.
The severity of BDD should not be underestimated. BDD is associated with markedly elevated rates of suicidal ideation and suicide attempts — higher than many other psychiatric conditions — reflecting the profound impact on quality of life, self-worth, and social functioning.
Diagnosis requires a comprehensive psychiatric assessment that distinguishes BDD from other conditions involving appearance concerns, evaluates insight and severity, and assesses for co-occurring conditions — particularly OCD, depression, anxiety, social anxiety, and eating disorders.
Many patients with BDD initially present to dermatologists or plastic surgeons rather than mental health services. Psychiatric referral and accurate diagnosis often come late in the clinical journey.
Cognitive Behavior Therapy (CBT) with Exposure and Response Prevention (ERP) adapted for BDD is the gold-standard psychological treatment. CBT-BDD targets distorted beliefs about appearance, the cognitive processes that maintain them, and the compulsive behaviours — mirror checking, reassurance seeking, concealment — that reinforce the preoccupation. Conducted directly in English, Russian and Hebrew.
Pharmacotherapy with SSRIs at typically higher doses than used for depression has a strong evidence base for BDD and is frequently used in combination with psychotherapy. Response requires adequate dosing and a sufficient trial period. Medication is prescribed individually. Digital prescriptions are issued through the Yarpa system.
For patients with low insight or delusional BDD presentations, the clinical approach requires adaptation — the therapeutic relationship and motivational work play a more central role.
All treatment is delivered within the framework of the Psychoergonomic Method.
If concerns about your appearance are consuming significant time, causing substantial distress, leading you to avoid social situations, or driving you toward medical or cosmetic interventions that have not provided relief — professional psychiatric assessment is appropriate.
BDD is a treatable condition. The right clinical approach can substantially reduce the power of the preoccupation and improve quality of life.
IsraClinic accepts patients for in-person consultation in Tel Aviv and online, in English, Russian and Hebrew. No referral is required.
Clinical Reviewer: Dr. Mark Zevin, MD — Senior Psychiatrist | IsraClinic | Last reviewed: 2026
BDD is not vanity — it is a recognised psychiatric condition that responds to the right treatment. Our team is available in English, Russian and Hebrew.